Communication processes about predictive genetic testing within high-risk breast cancer families: a two-phase study design

Communication processes about predictive genetic testing within high-risk breast cancer families: a two-phase study design

Abstract

The detection of a pathogenic variant in the BRCA1 or BRCA2 gene has medical and psychological consequences for both, affected mutation carriers and their relatives. A two-phase study with explanatory sequential mixed methods design examined the psychological impact of genetic testing and associated family communication processes. Analyzing a survey data of 79 carriers of a BRCA1 or BRCA2 mutation, the majority had general psychological distress independent of cancer diagnosis in the patients' history. The point prevalence of depression was 16.9%. Contrary to their subjective perception, the respondents' knowledge about those mutations was moderate. Despite the high rate of information transfer to relatives at risk (100%), their reported uptake of genetic testing was low (45.6%). Communication about the mutation detection was more frequent with female than with male relatives. In-depth focus group interviews revealed significant barriers to accessing genetic counseling including anxiety, uncertainty about the benefits of testing and about the own cancer risk, particularly among males. This study suggests that an adequate knowledge of the genetic background and psychological support is required to reduce emotional distress, to support familial communication and to facilitate genetic testing.

 


 

Sci Rep . 2021 Oct 11;11(1):20178. doi: 10.1038/s41598-021-98737-8.

Communication processes about predictive genetic testing within high-risk breast cancer families: a two-phase study design

Blomen CL et al.

Accedi al full text